Emmanuel Chamorey

Papers

Total Citations

H-Index

About

Emmanuel Chamorey is a distinguished researcher whose work bridges the frontiers of oncology and precision radiotherapy, with a particular focus on integrating advanced robotic technologies into cancer treatment. His research primarily explores the synergistic potential of combining stereotactic radioablation with neo-adjuvant chemotherapy, as exemplified by his seminal 2009 study on robotic stereotactic radioablation for breast tumors, which has garnered 30 citations and laid foundational insights for non-invasive, targeted cancer therapies. Chamorey has also made notable contributions to prostate cancer treatment, investigating the efficacy of CyberKnife™-based robotic radiotherapy, a technique that enhances dose accuracy while minimizing collateral damage to healthy tissues. His work, though modest in citation volume, is highly specialized and influential within the field of radiation oncology, reflecting a commitment to refining treatment protocols that improve patient outcomes. By championing the clinical application of robotic systems, Chamorey has helped pave the way for more personalized, less invasive cancer care, earning recognition among peers for his technical rigor and translational impact.